LANSING, Mich. — Neogen Corporation (“Neogen”) (NASDAQ: NEOG) announced that, at the special meeting of Neogen shareholders held today, Neogen shareholders voted to approve all proposals required in connection with the pending combination of the food safety business of 3M Company (“3M”) (NYSE: MMM) with Neogen, including the issuance of shares of Neogen common stock pursuant […]
LGC’s latest environmental, social and governance (ESG) report is now available, covering the period of 1 April 2021 – 31 March 2022. This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally. Euan O’Sullivan, LGC’s President and Chief Executive Officer, explained, “Last year, I shared […]
San Diego, CA – Proteintech Group today announces that it has established a new subsidiary company, Proteintech Genomics, based out of the thriving life sciences hub of San Diego, California. Proteintech Genomics is building out fully optimized and highly multiplexed proteomic assays to enhance multiomic capabilities across a number of spatial and single cell analysis […]
Genovis has signed a long-term licensing and supply agreement with a US based biotech company for the supply of SmartEnzymesTM to be used in the manufacturing of a clinical therapeutic agent. The new customer represents Genovis’ second partner in the Bioprocess application area. The new partner will initially use the Genovis enzyme for the preclinical process […]
BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications. 908 Devices expects the acquired technology to enable its mass spec […]
BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced that E. Kevin Hrusovsky is stepping down as Executive Chairman of its Board of Directors. Mr. Hrusovsky has served as the Chairman of Quanterix’ Board of Directors (the “Board”) since June 2014 and as Quanterix’ President and Chief Executive Officer from January […]
New CFO Hire Will Strengthen LI-COR’s Leadership Team Lincoln, NE. LI-COR, a leading developer of environmental and biotech products, is pleased to announce the appointment of Jim Gould as its new Chief Financial Officer. Tom Reslewic, CEO of LI-COR, said “We’re very excited to have Jim on board. His depth of experience, knowledge, and management […]
We are proud to announce on behalf of our company Eurofins Abraxis the launch of the new Domoic Acid (ASP) ELISA Test Kit for the detection of Domoic Acid in water, seawater and shellfish! The Domoic Acid ELISA is an immunoassay for the quantitative and sensitive detection of Domoic Acid. Domoic Acid is one of the toxins associated […]
Genovis AB and evitria AG today signed a service agreement to offer evitria’s customers fast LC-MS characterization of recombinant antibodies using Genovis proprietary enzyme technologies. evitria AG is a world leading service With this new service agreement, Genovis expands into a new business area that combines the ease of use of the SmartEnzymesTM with the competence […]
Company sharpens its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe. Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, today announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
